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Summary
An A-to-C base substitution at nucleotide position -61 in the promoter region of the human haptoglobin gene
(Hp) has been shown to be strongly associated with the haptoglobin 2-1 modified (Hp2-lmod) phenotype. In
order to investigate whether this base substitution is the cause of reduced expression of the Hp2 allele relative
to the Hp' allele in individuals with the Hp2-lmod phenotype, we used the chloramphenicol acetyl transferase
(CAT) expression system to evaluate promoter function. In HepG2 cells, which normally express their
endogenous haptoglobin genes, CAT plasmid constructs with the -61C base change in the promoter had about
10-fold-lower transcriptional activity after transfection than did the Hp control construct. The -61C
substitution also rendered the construct unresponsive to treatment by interleukin-6 after transfection into
Hep3B2 cells, which normally do not express haptoglobin but do so in response to stimulation by acute-phase
reactants. In addition, two base substitutions, T to A and A to G, at positions -104 and -55G, respectively, in
the promoter region of the Hp' allele, are also associated with the Hp2-lmod phenotype. CAT constructs with
both substitutions (-104A-55G) and with one substitution (-55G) showed activity similar to that in the Hp
control when transfected into both HepG2 and Hep3B2 cells, although interleukin-6 induction was less than
with the Hp control construct. These results further support the hypothesis that the Hp2-lmod phenotype
results, in part, from the -61C mutation in the promoter region of the Hp2 gene.
Introduction
Haptoglobin (Hp) is a serum protein synthesized in the
liver and binds free hemoglobin in the vasculature after
hemolysis. The Hp-hemoglobin complex is subse-
quently cleared by a receptor-mediated process in the
liver (reviewed by Bowman and Kurosky 1982). Hp
protein, which occurs as a tetramer (a2 ,2) in the circu-
lation, results from a single transcript that is subse-
quently processed into a and j3 subunits posttransla-
tionally (Raugei et al. 1983; vander Straten et al. 1983;
Yang et al. 1983). Smithies et al. (1962) discovered that
Received May 19, 1992; final revision received December 9, 1992.
Address for correspondence and reprints: Nobuyo Maeda, Depart-
ment of Pathology, CB 7525, University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599.
C 1993 by The American Society of Human Genetics. All rights reserved.
0002-9297/93/5205-0015$02.00
974
inherited structural variations in humans in the a sub-
unit of the Hp gene product resulted from three com-
mon alleles of the Hp locus: HplF, Hpls, and Hp2. The
a chains from the HplF and Hpls genes are distin-
guished from one another by their differential migra-
tion after denaturing gel electrophoresis. The a subunit
of the Hp2 allele contains a partial duplication that is
the result of an unequal crossover between the HpIF
and Hpls alleles. One of the consequences of this dupli-
cation is that the Hp2 gene product contains two cys-
teine residues-instead of one, as in the Hp' gene prod-
uct-which participate in the formation of complex
interchain bonds. The alleles give rise to three pheno-
types-Hpl-1, Hp2-2, and Hp2-1-distinguished in
starch gels by their distinct patterns formed by polymer-
izations involving the interchain disulfide bonds
(Smithies and Walker 1955; Smithies 1956).
A less common phenotype, Hp2-1 modified (mod),
Haptoglobin 2-1 Modified Phenotype
occurs in approximately 10% of black Americans (Gib-
lett 1959) and other black populations (Nance 1968). It
was identified as having an electrophoretic pattern simi-
lar to that of Hp2-1 (Connell and Smithies 1959), but in
the Hp2-lmod samples there appears to be a decreased
amount of the Hp2 polypeptide that participates in the
complex interchain bond formation (Giblett 1964).
This decrease in Hp2 polypeptide has been postulated
to result from the inheritance of an Hp2M allele (Giblett
and Steinberg 1960; Harris et al. 1960) or from the
action of trans-acting control elements on the Hp struc-
tural genes (Parker and Bearn 1963). Sutton and Karp
(1964) suggested, as a result of their family studies, that
the decrease results from two different alleles at the
Hp2 structural locus.
A recent study using direct sequencing of the Hp2
gene promoter regions in DNA samples taken from
unrelated black Americans revealed an A-to-C base
substitution in all of 11 individuals classified as Hp2-
imod and in none of 15 individuals classified as Hp2-1
(Maeda 1991). The A-to-C base substitution is thus
strongly associated with the Hp2-lmod phenotype. It is
located at nucleotide position -61, upstream from the
transcriptional start site of the Hp gene within one of
three interleukin-6 (IL-6) responsive elements in the
promoter region of Hp structural genes (Oliviero and
Cortese 1989). Consequently, the base substitution
could affect IL-6 responsiveness. In addition to the
base substitution at -61, the same study found that
there are two polymorphisms at -55 and -104 in the
Hp'F promoter region.
Here we characterize the expression of three poly-
morphisms found in the promoter regions of the Hp2
and HplF alleles associated with individuals of the
Hp2-lmod phenotype. Most important, the results in-
dicate that the -61C base substitution in the promoter
region of the Hp2 allele alters reporter gene expression
and IL-6 responsiveness in human hepatoma cell lines.
Less important, the -55G base substitution, which is
also in the promoter region of the Hp2 allele and the
-104A-55G substitution, which is in the promoter re-
gion of the HpIF allele, do not alter reporter gene ex-
pression and IL-6 responsiveness.
Material and Methods
Plasmid Constructs
Promoter sequences with and without a substitution
at nucleotide position -61 were amplified, by PCR,
from genomic DNA fragments and were cloned into
Bluescript plasmid vectors (Stratagene, La Jolla, CA).
Two restriction sites, XbaI and HindIl, were incorpo-
rated, respectively, into the 5' and 3' PCR primers, to
facilitate cloning. The PCR reaction and isolation of
the fragments were carried out according to methods
described elsewhere (Maeda 1991). Promoter se-
quences containing the -55 or the -104 and -55 point
mutations were similarly isolated. Plasmids containing
Hp promoter regions were constructed by cloning each
promoter fragment (647 bp) into a promoterless chlor-
amphenicol acetyl transferase (CAT) vector, pLCAT,
provided by Dr. C. Chae (Hwang and Chae 1989). The
nucleotide sequences of the promoter region in the re-
sulting CAT constructs were confirmed using a Se-
quenase kit (United States Biochemical, Cleveland) and
PCR primers. RSVCAT (Gorman et al. 1982) was a gift
from Dr. D. Sorcher of the University of North Caro-
lina at Chapel Hill. A P-galactosidase expression vector
was a gift from Dr. MacGregor of the University of
Texas (MacGregor and Caskey 1989). All plasmids
were purified by two cesium chloride gradients.
Cell Culture
The human hepatoma cell line HepG2 was provided
by Dr. B. Knowles of the Wistar Institute (Knowles et
al. 1980) and cultured as a monolayer in Eagle's mini-
mal essential medium supplemented with MEM vita-
mins (Gibco), 1 mM MEM sodium pyruvate (Gibco),
0.2 gg gentamicin/ml, and 10% FCS. The cells were
passed through a syringe with a 1/2-inch 22-gauge needle
to prevent clumping when plated. The human hepa-
toma cell line Hep3B2 (Darlington et al. 1986) was cul-
tured as a monolayer in Dulbecco's modified Eagle's
medium supplemented with 10% FCS.
The human recombinant IL-6 was a gift from Dr. J.
Snouwaert of the University of North Carolina at Cha-
pel Hill. Its activity has been assayed as described else-
where (Snouwaert et al. 1991). For induction experi-
ments, Hep3B2 cells were treated with recombinant
IL-6 at 3 and 30 nM for 48 h after transfection.
DNA Transfections
DNA transfections were performed by a calcium
phosphate coprecipitation technique (Gorman 1985).
The cells were plated at either 60% confluency
(Hep3B2 cells) or 80% confluency (HepG2 cells) in 60-
mm culture dishes the day before transfection. The
cells were fed fresh media 3-4 h (Hep3B2 cells) or 5-6 h
(HepG2 cells) prior to transfection. Cells were trans-
fected with 10 ,ug of CAT plasmid DNA and with 2.5
jg (Hep3B2 cells) or 4 jig (HepG2 cells) of CMVP-
galactosidase plasmid, per 60-mm culture dish. For IL-6
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induction experiments, the mixture described above
was prepared in triplicate and was divided between
three 60-mm culture dishes.
CAT Assay
The transfected cells were harvested 48 h after trans-
fection and were assayed for f3-galactosidase activity,
according to a method described elsewhere (An et al.
1982), to normalize the transfection efficiency. The
CAT activity was measured and quantitated (Gorman
1985) by cutting the area of the TLC plate correspond-
ing to the acetylated and nonacetylated forms of the
["4C]-labeled chloramphenicol substrate (ICN) and
counting them in a liquid scintillation counter. The
proportion of the total quantity of [14C] chlorampheni-
col that was acetylated was then determined.
Results
Decreased Activity of -6 IC Promoter in CAT
Expression Vector
Four plasmid constructs used in this study are illus-
trated in figure 1. The promoter sequence described by
Maeda (1985) is referred to as "Hp control," and those
carrying differences from this sequence are named
"-61C," "-SSG," and "-104A-55G," to indicate the
base substitutions and their nucleotide positions. The
constructs were transfected into HepG2 cells, and tran-
sient expression of the CAT gene was measured.
HepG2 cells normally express Hp (Knowles et al. 1980),
and so measurement of relative Hp promoter activities
was expected to be possible in these cells.
Table 1 summarizes three experiments in which the
transcriptional activity of the four plasmids was mea-
sured as the percentage of the total acetylated chloram-
phenicol that was converted to the mono- and diacetyl-
ated forms. Transfections in experiment 1 were carried
out using a single dish of cells per DNA-calcium phos-
phate precipitation of each CAT construct. In this ex-
periment, CAT activities measured from cell extracts
were relatively low, with the highest activity, 24% con-
version, resulting from -104A-55G-transfected cells
and with the lowest CAT activity, 1% conversion, re-
sulting from -61C-transfected cells. In experiment 2,
transfections were done in triplicate for each construct.
The DNA-calcium phosphate precipitate was divided
among three dishes of cells for each construct, and
CAT activities measured from extracts from these cells
were averaged. In this experiment, high CAT activities
were observed, with the highest activity, 93% conver-
sion, resulting again from -104A-55G-transfected
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Figure I Four varieties of the Hp promoter region (-611 to
+36) used to study the function of promoters that are linked to
alleles associated with the Hp2-lmod phenotype. A, PCR-amplified
promoter region from nucleotide position -611 to +36, which in-
cludes three IL-6 responsive elements (unmarked boxes) and three
nucleotide positions (solid vertical arrows) that are polymorphic. The
PCR primers used to amplify the region are indicated by striped hori-
zontal arrows. The asterisk (*) indicates a mismatch site that removes
the Hp initiation codon, ATG. B, Four varieties of promoter-Hp
control, -61C, -55G, and -104A-SSG-shown with their variant
nucleotide. C, CAT expression vector, pLCAT, with the site used for
cloning the variant promoters indicated. Ori = orn site; AMP = ampi-
cillin gene; and CAT = CAT gene. Arrows indicate direction of tran-
scription.
again from -61C-transfected cells. Because the levels
of CAT expression in experiment 2 approach 100%
from -55G and -104A-55G-transfected cells, con-
version values are also recorded as the percentage of
diacetylated chloramphenicol relative to the total
chloramphenicol (data in parentheses in table 1); this
allows a better assessment of the relative transcriptional
activities of the more active constructs. In the third
experiment, results from two independent transfec-
tions were averaged. In this experiment the CAT activi-
ties measured were 49% and 12% for the -55G and
-104A-55G constructs, respectively, while the activ-
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Table I
CAT Activity from Transfected HepG2 Cells (% Conversion)
Experiment Experiment Experiment
CAT Construct 1 2a 3b
Hp control .......... 15 83 (0.6) 26
-61C . ......... 1 11(0.1) 1
-55G. ............. 6 91(1.2) 49
-104A-55G ......... 24 93 (5.2)c 12
a Average values from experiment done in triplicate (data in paren-
theses are average percentage of diacetylated chloramphenicol rela-
tive to total chloramphenicol).
b Average values from two independent experiments.
c From two replicates.
ity for Hp control was 26%. However, cells transfected
with the -61C construct again had very low activity
(1%). While we noted inconsistencies in CAT expres-
sion with the -55G and -104A-55G constructs,
across several plasmid preparations, the activity for the
-61C plasmid preparations has remained consistently
lower than all other tested plasmids.
The data are all in agreement in showing that the
A-to-C base substitution at nucleotide position -61
reduces the transcriptional activity of the Hp promoter
in HepG2 cells. This reduction is about 13-fold relative
to the Hp control construct in experiment 1, at least
6-fold in experiment 2, and as high as 26-fold in experi-
ment 3. The data also show that the -104A-55G con-
struct has more CAT activity than does the Hp control
in experiments 1 and 2 but less in experiment 3. The
activity of the -55G construct was lower than that of
the Hp control in experiment 1 but higher in experi-
ments 2 and 3. Thus the activities of the -104A-55G
and -55G constructs are not significantly different
from that of the Hp control. From these experiments,
we conclude that the -61C base substitution, which is
strongly associated with the Hp2-lmod phenotype, se-
verely affects the transcriptional activity of the Hp pro-
moter.
Nucleotide -61 C Impairs the Responsiveness of the Hp
Promoter to Human Recombinant IL-6
Hp gene promoters confer IL-6 responsiveness on
CAT reporter genes when transfected into Hep3B2
cells (Oliviero and Cortese 1989). These cells do not
normally synthesize Hp mRNA (Oliviero et al. 1987),
but, on treatment with acute-phase mediators, such as
IL-6, Hp synthesis is induced (Darlington et al. 1986;
Gauldie et al. 1987; Oliviero et al. 1987; Oliviero and
Cortese 1989). To investigate the effects of the various
base substitutions on the responsiveness of the Hp pro-
moters to IL-6, the four CAT constructs shown in fig-
ure 1 were transfected into Hep3B2 cells. Cells were
then treated with 0, 3, and 30 nM of IL-6. The results
of the IL-6 induction are shown in figure 2 and are
summarized in table 2. No induction of CAT activity
was observed in transfections with the positive control
RSVCAT (data not shown).
The treatment of cells by IL-6 had the most pro-
found effect on cells transfected with the Hp control
construct. CAT activity increased an average of 19-fold
in cells treated with 30 nM IL-6, compared with activ-
ity in untreated cells. In contrast, we observed only an
average twofold increase in activity in extracts from
-61C-transfected cells. Note that both the Hp control
and -61C constructs in the untreated Hep3B2 cells
had very low activity (1.4% conversion) in untreated
Hep3B2 cells.
CAT activity from -55G-transfected cells and CAT
activity from -104A-55G-transfected cells both in-
creased an average of 10-fold when treated with 30 nM
IL-6. Interestingly, while the induction ratios for both
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Figure 2 IL-6 induction of CAT synthesis by Hp promoter
constructs containing base substitutions associated with the Hp2 and
Hp' alleles in the Hp2-lmod phenotype. Autoradiogram of the ["'C]
chloramphenicol (CAM) and acetylated chloramphenicol resolved by
thin-layer chromatography. The 1- and 3-acetylated forms of acetyl-
chloramphenicol are indicated (Ac-CAM), as is the diacetylated form
(diAc-CAM). Hep3B2 cells were transfected by CaPO4 coprecipitates
of a marker P-galactosidase plasmid (see text) and with Hp control,
-61C, -55G, and -104A-55G CAT constructs. The next day the
plates were washed and fed with fresh media containing 0 (lanes 1), 3
(lanes 2), or 30 (lanes 3) nM of recombinant IL-6 and incubated at
37°C and with 5% CO2 for 48 h. After 48 h, to allow correction for
transfection efficiencies, ,B-galactosidase activity was determined on
the same samples. CAT activity was determined as described in the




Percent CAT Conversion and IL-6 Induction Ratios from Transfected Hep3B2 Cells
IL-6 Concentration
(nM) Hp Control -61C -55G -104A-55G
Experiment 1 .......... 0 1.4 1.4 5.5 3.8
3 16.0 6.0 19.7 3.9
30 29.0 3.1 47.1 42.4
Experiment 2 .......... 0 1.5 1.6 1.9 10.6
3 4.1 2.4 6.0 28.7
30 26.7 2.4 13.4 91.0
Induction ratioa 19.2 1.8 8.2 9.3
a Average percent conversion at 30 nM IL-6/average percent conversion at 0 nM IL-6.
CAT activities in untreated Hep3B2 cells are about
threefold higher than that of the Hp control.
Marinkovic and Baumann (1990) reported experi-
ments demonstrating IL-6 induction of CAT activity in
HepG2 cells transfected with CAT constructs contain-
ing rat Hp promoters. We, therefore, repeated the in-
duction studies by using HepG2 cells and obtained,
from two independent experiments, seven-, five-, and
fourfold induction for the Hp control, -55G, and
-104A-55G constructs, respectively, while -61C
showed twofold induction. The results are consistent
with those observed in transfection experiments with
Hep3B2 cells, although the magnitude of induction is
about half the levels.
From these experiments, we conclude that the A-to-
C nucleotide substitution at -61 impairs Hp promoter
responsiveness to IL-6 about 10-fold in Hep3B2 cells,
compared with the Hp control. The effects of the
-55G and -104A-SSG substitutions are less marked,
showing induction approximately twofold less than
that in the Hp control.
Discussion
The Hp2-lmod phenotype has been characterized as
a normal Hp variant exhibiting a decreased quantity of
one of its components. We have shown here that an
A-to-C base substitution at nucleotide position -61 in
the Hp gene promoter causes it to have a decreased
transcriptional activity as measured by CAT assays.
This base substitution had been previously identified
and linked to the Hp2 allele in individuals who are
Hp2-lmod (Maeda 1991). CAT activity, measured in
HepG2 cells transfected with -61C CAT construct,
was about 10-fold lower than that for cells transfected
with the CAT construct having an A at nucleotide posi-
tion -61 (Hp control). Since HepG2 cells normally ex-
press Hp, these observations strongly implicate the
-61C promoter with the decrease in Hp2 polypeptide
observed in gel electrophoresis of sera from Hp2-lmod
individuals.
In addition to exhibiting decreased levels of Hp2
polypeptide, the Hp2-lmod phenotype may exhibit in-
creased levels of Hpl polypeptide (Bowman and Ku-
rosky 1982; Maeda 1991). In 10 of 11 individuals classi-
fied as Hp2-lmod, there was an Hp"F allele with a
T-to-A base substitution at nucleotide position -104
and with an A-to-G base substitution at nucleotide po-
sition -55 (Maeda 1991). Transcriptional activity mea-
sured in HepG2 cells transfected with the -104A-55G
promoter construct showed activity that was not con-
sistently higher or lower than that for the Hp control.
In addition, the -104A-55G promoter was also found
in individuals who have the classical Hp2-1 phenotype.
Together these data suggest that this promoter is not
the direct cause of the Hp2-lmod phenotype (Maeda
1991). The -55 A-to-G base substitution was identified
in only two serum samples classified as "possible Hp2-
imod" (Maeda 1991). Such samples have characteris-
tics in native gel electrophoresis that are similar to but
not as extreme as those of typical Hp2-lmod samples.
The relative promoter activity of the -55G construct
compared with that of the Hp control was also incon-
sistent in our CAT assays.
Oliviero et al. (1987) have shown in transient expres-
sion studies on Hp promoter-deletion mutants the
DNA sequence between nucleotide positions -186
and -38 is essential for cell-specific transcription and
maximal inducibility by IL-6. We have here demon-
strated in induction experiments with Hep3B2 cells
that the -61 A-to-C base substitution impairs the abil-
ity of the Hp promoter to respond to treatment with
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IL-6. Our results show that CAT activity with the -61C
construct is induced 10-fold less than with the Hp con-
trol construct and about 5-fold less than with the -55G
and -104A-55G constructs. A previous study by Ohi-
viero and Cortese (1989) identified in a region that in-
cludes our CAT construct promoters three cis-acting
IL-6 responsive elements (fig. 1) that are bound, in in
vitro studies, by several complexes of IL-6 dependent
proteins. The -61C base substitution that we have as-
sociated with the Hp2-lmod phenotype falls within
one of those elements and causes a decrease in IL-6
responsiveness, thus confirming the importance of this
sequence for IL-6 response. Similarly, Marinkovic and
Baumann (1990) showed that a single base change can
alter the IL-6 responsiveness of the rat Hp gene pro-
moter severalfold. Our results suggest that the -61C
base substitution associated with the Hp2-lmod pheno-
type may cause a decreased in vivo response to IL-6.
Perhaps individuals with this mutation may not be able
to increase the transcription of their Hp2 allele during
an acute response. Induction levels observed with the
-55G and -104A-55G constructs were lower than
those for the Hp control, although the CAT activity for
the untreated transfections was always higher than
those for the Hp control in transfection experiments
with Hep3B2 cells. Individuals with these mutations
may be able to reach the same Hp levels, in response to
acute-phase mediators, as do individuals without muta-
tions-but only because they start from higher basal
levels. IL-6 induction studies employing HepG2 cells
demonstrated that the relative amount of activity was
the same as that in Hep3B2 cells, albeit at lower levels.
In conclusion, our data demonstrate that the Hp2-
imod phenotype results from various combinations of
the gene promoter activity of Hp2 and Hp' alleles in
heterozygous individuals. We have shown that the
-61C base substitution linked to the Hp2 allele de-
creases both normal and IL-6-induced expression of
CAT in transient-expression studies. Although results
obtained from the expression of episomal DNA in cell
culture systems have limitations in explaining chromo-
somal gene expression patterns, our data directly con-
nect the Hp gene promoter polymorphisms with the
decreased levels of Hp2 polypeptide associated with
the Hp2-lmod phenotype (Maeda 1991). The lack of
response of the -61C construct to IL-6 in Hep3B2 cells
and HepG2 cells supports the hypothesis that the vari-
ability of the Hp2-lmod phenotype may result from
the different influence that acute-phase mediators have
on the promoters linked to the Hp' allele and Hp2
allele. We are currently carrying out longitudinal stud-
ies that would allow the pattern of expression of Hp in
Hp2-1mod individuals to be observed at different
stages of acute-phase induction, to further test this hy-
pothesis.
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